EdgarLookup

Tonix Pharmaceuticals Holding Corp. — All Filings

1,000 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 4 4/A 424B3 424B4 424B5 5 8-A12B 8-A12G 8-K 8-K/A ARS AW CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A EFFECT FWP NT 10-K NT 10-Q POS AM POS EX PRE 14A RW S-1 S-1/A S-3 S-3/A S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SCHEDULE 13G/A 0000102909-26-002406 Mar 27, 2026
8-K CURRENT REPORT 0001999371-26-006915 Mar 26, 2026
PRE 14A PRELIMINARY PROXY STATEMENT 0001999371-26-006640 Mar 20, 2026 May 7, 2026
4 0001999371-26-006235 Mar 18, 2026
8-K CURRENT REPORT 0001999371-26-006169 Mar 18, 2026 Mar 16, 2026
ARS ANNUAL REPORT TO SECURITY HOLDERS 0001999371-26-005744 Mar 13, 2026 Dec 31, 2025
8-K CURRENT REPORT 0001999371-26-005742 Mar 13, 2026 Mar 12, 2026
10-K ANNUAL REPORT 0001999371-26-005730 Mar 12, 2026 Dec 31, 2025
8-K CURRENT REPORT 0001999371-26-005466 Mar 10, 2026
8-K CURRENT REPORT 0001999371-26-004897 Mar 3, 2026
4 0001999371-26-004389 Feb 26, 2026 Feb 24, 2026
4 FORM 4 - SAENGER 0001999371-26-004388 Feb 26, 2026 Feb 24, 2026
4 CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-004387 Feb 26, 2026 Feb 24, 2026
4 CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-004386 Feb 26, 2026 Feb 24, 2026
4 CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-004385 Feb 26, 2026 Feb 24, 2026
5 0001999371-26-003371 Feb 17, 2026 Dec 31, 2025
8-K CURRENT REPORT 0001999371-26-002429 Feb 3, 2026
SCHEDULE 13G/A 0000102909-26-000297 Jan 30, 2026
SCHEDULE 13G/A 0002012383-26-000796 Jan 21, 2026
SCHEDULE 13G 0000902664-25-005443 Dec 31, 2025
8-K CURRENT REPORT 0001999371-25-021283 Dec 29, 2025
424B5 PROSPECTUS SUPPLEMENT 0001999371-25-021282 Dec 29, 2025
8-K CURRENT REPORT 0001999371-25-021194 Dec 29, 2025
8-K CURRENT REPORT 0001999371-25-020361 Dec 16, 2025
8-K CURRENT REPORT 0001999371-25-019833 Dec 9, 2025
8-K CURRENT REPORT 0001999371-25-018430 Nov 24, 2025
424B5 PROSPECTUS SUPPLEMENT 0001999371-25-018393 Nov 21, 2025
8-K CURRENT REPORT 0001999371-25-018392 Nov 21, 2025
8-K CURRENT REPORT 0001999371-25-018108 Nov 18, 2025
8-K CURRENT REPORT 0001999371-25-017964 Nov 17, 2025
10-Q QUARTERLY REPORT 0001999371-25-017370 Nov 10, 2025 Sep 30, 2025
8-K CURRENT REPORT 0001999371-25-017369 Nov 10, 2025
SCHEDULE 13G 0000102909-25-000328 Oct 31, 2025
8-K CURRENT REPORT 0001999371-25-016108 Oct 27, 2025
8-K CURRENT REPORT 0001999371-25-015796 Oct 22, 2025
SCHEDULE 13G/A 0002012383-25-002913 Oct 17, 2025
8-K CURRENT REPORT 0001999371-25-014776 Oct 7, 2025
8-K CURRENT REPORT 0001999371-25-014216 Sep 30, 2025
8-K CURRENT REPORT 0001999371-25-014108 Sep 29, 2025
8-K CURRENT REPORT 0001999371-25-013498 Sep 18, 2025
8-K CURRENT REPORT 0001999371-25-013413 Sep 17, 2025
EFFECT 9999999995-25-002831 Sep 4, 2025
S-3/A AMENDMENT TO FORM S-3 0001999371-25-012583 Sep 4, 2025
CORRESP 0001999371-25-012501 Sep 3, 2025
CORRESP 0001999371-25-012500 Sep 3, 2025
CORRESP 0001999371-25-012337 Aug 29, 2025
4 STATEMENT OF CHANGES OF BENEFICIAL OWNERSHIP 0001999371-25-011836 Aug 21, 2025
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-011754 Aug 20, 2025
8-K CURRENT REPORT 0001999371-25-011510 Aug 18, 2025
8-K CURRENT REPORT 0001999371-25-011478 Aug 15, 2025